Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,722.40
(
0.01%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.69
(
1.21%
)
Bitcoin
70,920.00
(
1.46%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 185242

Monday, 09/12/2016 10:34:46 AM

Monday, September 12, 2016 10:34:46 AM

Post# of 257262
JNJ submits MAA for FDC consisting of Prezista and GILD’s TAF/Emtriva/Cobicistat (a/k/a D/C/F/TAF):

http://finance.yahoo.com/news/janssen-submits-marketing-authorisation-application-113000014.html

By prior agreement with GILD (#msg-109435833), JNJ controls the development and commercialization of this regimen.

(Prezista boosted with Cobicistat in an FDC is already sold under the brand name, Prezcobix in the US (#msg-110465571) and the brand name, Rezolsta in the EU.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now